FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/14/2024
Back to search
Official data from USPTO
INDUCE-SEQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INDUCE-SEQ
ST13
US500000079362452Class
1, 5, 9, 10, 42, 44
Filing
79362452
Registration
7410775
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
12/14/2024
Trademark type
Word
Nice classes
1, 5, 9, 10, 42, 44
Filing date
08/04/2022
Registration date
06/11/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
STEINPFAD, SARAH
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BROKEN STRING BIOSCIENCES LIMITED
Representatives
Brendan J. Hughes Cooley LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations for use in agricultureexcept fungicidesherbicidesinsecticidesparasiticides
Class 5
Pharmaceutical preparations for the treatment of cancercardiovascular diseases and disordersneurological diseases and disorderssleep conditionsdiseases and disorderscentral nervous system conditionsdiseases and disordersrare diseases and disordersgenetic diseases and disordersoncological and hematological diseases and disordersdermatological diseases and disordersbone diseases and disordersrespiratory diseases and disordersendocrinological diseases and disorderscirculatory diseases and disordersgastroenterological diseases and disordershormonal diseases and disordersdiabetic diseases and disordersdigestive diseases and disordersmuscular diseases and disordersimmune system diseases and disordersmetabolic diseases and disordersocular diseases and disorders; medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; pharmaceutical preparations for use in gene and cell therapies for the treatment of cancercardiovascular diseases and disorderspsychiatric diseases and disordersneurological diseases and disorderssleep conditionsdiseases and disorderscentral nervous system conditionsdiseases and disordersrare diseases and disordersgenetic diseases and disordersoncological and hematological diseases and disordersdermatological diseases and disordersbone diseases and disordersrespiratory diseases and disordersendocrinological diseases and disorderscirculatory diseases and disordersgastroenterological diseases and disordershormonal diseases and disordersdiabetic diseases and disordersdigestive diseases and disordersmuscular diseases and disordersimmune system diseases and disordersmetabolic diseases and disordersocular diseases and disorders; pharmaceutical preparations for use in chemotherapies; diagnostic kits for medical purposes comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancercardiovascular diseases and disorderspsychiatric diseases and disordersneurological diseases and disorderssleep conditionsdiseases and disorderscentral nervous system conditionsdiseases and disordersrare diseases and disordersgenetic diseases and disordersoncological and hematological diseases and disordersdermatological diseases and disordersbone diseases and disordersrespiratory diseases and disordersendocrinological diseases and disorderscirculatory diseases and disordersgastroenterological diseases and disordershormonal diseases and disordersdiabetic diseases and disordersdigestive diseases and disordersmuscular diseases and disordersimmune system diseases and disordersmetabolic diseases and disordersocular diseases and disorders; analytical test kits being medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancercardiovascular diseases and disorderspsychiatric diseases and disordersneurological diseases and disorderssleep conditionsdiseases and disorderscentral nervous system conditionsdiseases and disordersrare diseases and disordersgenetic diseases and disordersoncological and hematological diseases and disordersdermatological diseases and disordersbone diseases and disordersrespiratory diseases and disordersendocrinological diseases and disorderscirculatory diseases and disordersgastroenterological diseases and disordershormonal diseases and disordersdiabetic diseases and disordersdigestive diseases and disordersmuscular diseases and disordersimmune system diseases and disordersmetabolic diseases and disordersocular diseases and disorders
Class 9
Downloadable computer software for the analysis of genomic datagene editing datacell culture datatherapeutic development datapatient data; downloadable mobile application software for the analysis of genomic datagene editing datacell culture datatherapeutic development datapatient data; apparatus and instruments for scientific or research purposeslaboratory apparatus and instruments for genome sequencingnot for medical purposes
Class 10
Blood test collection kits comprised of blood collection needlesblood collecting tubesblood collection bags for medical purposes; radiation therapy devices
Class 42
Analytical laboratory servicesscientific laboratory services; pharmaceutical research and development services; testinginspectionresearch and development of pharmaceutical preparations for gene therapy; testinginspectionresearchdevelopment of pharmaceutical preparations for cell therapies; genome scientific research services; development of new technology for others in the field of medical devices and medical diagnostic apparatuses; medical research services; medical research in the field of infectious disease monitoring and surveillance services; research and development services in the field of antibodies; researchdevelopment and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; medical research in the field of oncology; toxicity testing and analysis for foodstuffs for scientific research purposes; toxicity testing and analysis for household products for scientific research purposes; computer software development; providing temporary use of online non-downloadable software and software applications using artificial intelligence for medical analysis; software as a service (SaaS) featuring software for the analysis of genomic datagene editing datacell culture datatherapeutic development datapatient data; platform as a service (PaaS) featuring computer software platforms for the analysis of genomic datagene editing datacell culture datatherapeutic development datapatient data; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis
Class 44
Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical diagnostic blood testing for identifying and determining the presence and stage of diseases; genome editing therapeutics
Publications
History of USPTO decisions and trademark events.
37 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/21/2024
FIMP
FINAL DISPOSITION PROCESSED
11/21/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2024
PUBO
PUBLISHED FOR OPPOSITION
03/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/21/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/21/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/21/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/12/2023
RFNT
REFUSAL PROCESSED BY IB
08/01/2023
ATRV
ATTORNEY REVIEW COMPLETED
07/25/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
07/19/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/08/2023
RFRR
REFUSAL PROCESSED BY MPU
07/08/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
06/11/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/31/2023
CNRT
NON-FINAL ACTION WRITTEN
05/30/2023
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
05/26/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/26/2023
CNRT
NON-FINAL ACTION WRITTEN
05/25/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
05/24/2023
DOCK
ASSIGNED TO EXAMINER
05/23/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/15/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2023
Continuous trademark protection
Get notified about every new filing that threatens INDUCE-SEQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.